“On 19 April 2013, the OFT announced that it had issued a Statement of Objections following its investigation into patent litigation settlement agreements (PLSAs) in the pharmaceutical sector.”
Competition Bulletin from Blackstone Chambers, 3rd May 2013
Source: www.competitionbulletin.com
